These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 8625136)

  • 61. Successful treatment of intrathecal methotrexate overdose by using ventriculolumbar perfusion and intrathecal instillation of carboxypeptidase G2.
    O'Marcaigh AS; Johnson CM; Smithson WA; Patterson MC; Widemann BC; Adamson PC; McManus MJ
    Mayo Clin Proc; 1996 Feb; 71(2):161-5. PubMed ID: 8577190
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Survey of Methotrexate Prescription and Blood Concentration in Patients Treated with High-Dose Methotrexate].
    Kobayashi S; Yasu T; Momo K; Ohno N
    Gan To Kagaku Ryoho; 2020 Jul; 47(7):1063-1067. PubMed ID: 32668853
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Toxic epidermal necrolysis following combination of methotrexate and trimethoprim-sulfamethoxazole.
    Yang CH; Yang LJ; Jaing TH; Chan HL
    Int J Dermatol; 2000 Aug; 39(8):621-3. PubMed ID: 10971734
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Is hypoalbuminemia a risk factor for high-dose methotrexate toxicity in children with acute lymphoblastic leukemia?
    Barakat S; Assem H; Salama M; Mikhael N; El Chazli Y
    J Egypt Natl Canc Inst; 2022 Apr; 34(1):17. PubMed ID: 35434757
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Commentary.
    Fox E; Balis FM
    Clin Chem; 2010 Dec; 56(12):1795. PubMed ID: 21119037
    [No Abstract]   [Full Text] [Related]  

  • 66. Suspected methotrexate toxicity from omeprazole: a case review of carboxypeptidase G2 use in a methotrexate-experienced patient with methotrexate toxicity and a review of the literature.
    McBride A; Antonia SJ; Haura EB; Goetz D
    J Pharm Pract; 2012 Aug; 25(4):477-85. PubMed ID: 22550162
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A European consensus recommendation on the management of delayed methotrexate elimination: supportive measures, leucovorin rescue and glucarpidase treatment.
    Bielack SS; Soussain C; Fox CP; Houillier C; Murciano T; Osborne W; Zinzani PL; Rizzari C; Schwartz S
    J Cancer Res Clin Oncol; 2024 Oct; 150(10):441. PubMed ID: 39356310
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Early therapeutic drug monitoring of methotrexate and its association with acute kidney injury: A retrospective cohort study.
    Tentoni N; Hwang M; Villanueva G; Combs R; Lowe J; Ramsey LB; Taylor ZL; Carrillo TM; Aumente MD; López-Viñau López T; Rizzari C; Howard SC
    Cancer Med; 2024 Sep; 13(17):e70176. PubMed ID: 39254047
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Serum creatinine and creatinine clearance for predicting plasma methotrexate concentrations after high-dose methotrexate chemotherapy for the treatment for childhood lymphoblastic malignancies.
    Xu WQ; Zhang LY; Chen XY; Pan BH; Mao JQ; Song H; Li JY; Tang YM
    Cancer Chemother Pharmacol; 2014 Jan; 73(1):79-86. PubMed ID: 24158402
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Effects of hydration on plasma concentrations of methotrexate in patients with osteosarcoma treated with high doses of methotrexate].
    Ferrari S; Orlandi M; Avella M; Caldora P; Ferraro A; Ravazzolo G; Bacci G
    Minerva Med; 1992 May; 83(5):289-93. PubMed ID: 1589134
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Hyper-alkalinization without hyper-hydration for the prevention of high-dose methotrexate acute nephrotoxicity in patients with osteosarcoma.
    Mir O; Ropert S; Babinet A; Alexandre J; Larousserie F; Durand JP; Enkaoua E; Anract P; Goldwasser F
    Cancer Chemother Pharmacol; 2010 Nov; 66(6):1059-63. PubMed ID: 20155268
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Challenging the clinical relevance of folinic acid over rescue after high dose methotrexate (HDMTX).
    Cohen IJ
    Med Hypotheses; 2013 Nov; 81(5):942-7. PubMed ID: 24035689
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Delayed methotrexate clearance in a patient with sickle cell anemia and osteosarcoma.
    Mantadakis E; Rogers ZR; Smith AK; Quigley R; Ratliff AF; Kamen BA
    J Pediatr Hematol Oncol; 1999; 21(2):165-9. PubMed ID: 10206466
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Carboxypeptidase-G2 rescue of methotrexate intoxication].
    Grill J; Amigo-Ferreiro ME; Schoepfer C; Bonnay M; Valteau-Couanet D; Hartmann O; Vassal G
    Bull Cancer; 1998 Dec; 85(12):1066. PubMed ID: 9917559
    [No Abstract]   [Full Text] [Related]  

  • 75. Methotrexate nephrotoxicity: Novel treatment, new approach.
    Iqbal S; Armaghani A; Aiyer R; Kazory A
    J Oncol Pharm Pract; 2013 Dec; 19(4):373-6. PubMed ID: 24255083
    [TBL] [Abstract][Full Text] [Related]  

  • 76. High-dose methotrexate therapy of childhood acute lymphoblastic leukemia: lack of relation between serum methotrexate concentration and creatinine clearance.
    Joannon P; Oviedo I; Campbell M; Tordecilla J
    Pediatr Blood Cancer; 2004 Jul; 43(1):17-22. PubMed ID: 15170885
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Rechallenge With High-Dose Methotrexate After Treatment With Glucarpidase in Adult Patients With Lymphoma.
    Truong HL; Barreto JN; Mara KC; Hampel PJ; Micallef IN; Nowakowski GS; Thanarajasingam G; Thompson CA; Wang Y; Witzig TE; Herrmann SM; Leung N
    JCO Oncol Pract; 2024 Jun; 20(6):797-807. PubMed ID: 38408299
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Renal dysfunction during and after high-dose methotrexate.
    Green MR; Chamberlain MC
    Cancer Chemother Pharmacol; 2009 Mar; 63(4):599-604. PubMed ID: 18504579
    [TBL] [Abstract][Full Text] [Related]  

  • 79. High-dose methotrexate and/or leucovorin rescue for the treatment of children with lymphoblastic malignancies: do we really know why, when and how?
    Sterba J; Valík D; Bajciová V; Kadlecová V; Gregorová V; Mendelová D
    Neoplasma; 2005; 52(6):456-63. PubMed ID: 16284689
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Successful carboxypeptidase G2 rescue in delayed MTX-elimination due to renal failure.
    Hum M; Kamen BA
    Pediatr Hematol Oncol; 1995; 12(6):521-4. PubMed ID: 8588996
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.